FAP-α and uPA show different expression patterns in premalignant and malignant esophageal lesions

Ultrastructural Pathology

Volumn 32, Issue 3, 2008, Pages 89-96

  Goscinski, Mariusz Adam ^a,b   Suo, Zhenhe ^a   Flørenes, Vivi Ann ^a   Vlatkovic, Ljiljana ^a   Nesland, Jahn Marthin ^a   Giercksky, Karl Erik ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Adenocarcinoma; Barrett's esophagus; Dysplasia; Extracellular matrix; Serine proteases

Indexed keywords

PROTEINASE; SEPRASE; UROKINASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER TISSUE; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; WESTERN BLOTTING;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; BARRETT ESOPHAGUS; BLOTTING, WESTERN; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PRECANCEROUS CONDITIONS; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 45849106533     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120802034934     Document Type: Article

References (28)

1. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994;79:185-188.
2. Chen W-T, Kelly T. Seprase complexes in cellular invasiveness. Cancer Metastasis Rev. 2003;22:259-269.
3. Okada K, Chen W-T, Iwasa S, Jin X, Yamane T, Ooi A. Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology. 2003;65:363-370.
4. Iwasa S, Jin X, Okada K, Mitsumata M, Ooi A. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett. 2003;199:91-98.
5. Mori Y, Kono K, Matsumoto Y, Fujii H, Yamane T, Mitsumata M, Chen W-T. The expression of type II transmembrane serine protease (seprase) in human gastric carcinoma. Oncology. 2004;67:411-419.
6. Wesley UV, Albino AP, Tiwari S, Houghton AN. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med. 1999;190:311-322.
7. Ramirez-Montagut T, Blachere NE, Sviderskaya EV, et al. FAP alpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene. 2004;23:5435-5446.
8. Kikkawa F, Kajiyama H, Shibata K, Ino K, Nomura S, Mizutani S. Dipeptidyl peptidase IV in tumor progression. Biochim Biophys Acta. 2005;1751:45-51.
9. Kelly T. Fibroblast activation protein-a and dipeptidyl peptidase IV (CD 26): cell-surface proteases that activate cell signalling and are potential targets for cancer therapy. Drug Resist Updat. 2005;8:51-58.
10. Moehrle MC, Schlagenhauff BE, Klesen C, Rassner G. Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histological study. J Cutan Pathol. 1995;22:241-247.
11. Chaves P, Cardoso P, de Almeida JC, Pereira AD, Leitao CN, Soares J. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation. Hum Pathol. 1999;30:1291-1295.
12. Aoyama A, Chen W-T. A 170-kDa membrane-bound protease is associated with expression of invasiveness by human malignant melanoma cells. Proc Natl Acad Sci USA. 1990;87:8296-8300.
13. Kelly T, Mueller SC, Yeh Y, Chen W-T. Invadopodia promote proteolysis of a vide variety of extracellular matrix proteins. J Cell Physiol. 1994;158:299-308.
14. Pineiro-Sanchez ML, Goldstein LA, Dodt J, et al. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem. 1997;272:7595-7601.
15. Ghersi G, Zhao Q, Salamone M, Yeh Y, Zucker S, Chen W-T. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res. 2006;66:4652-4661.
16. Chen D, Kennedy A, Wang JY, et al. Activation of EDTA-resistant gelatinases in malignant human tumors. Cancer Res. 2006;66:9977-9785.
17. Nishino N, Aoki K, Tokura Y, Sakaguchi S, Takada Y, Takada A. The urokinase type of plasminogen activator in cancer of digestive tracts. Thromb Res. 1988;50:527-535.
18. Sier CF, Verspaget HW, Griffioen G, et al. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis. Gastroenterology. 1991;101:1522-1528.
19. Hewin DF. Randomized comparison of polyglycolic acid and polyglyconate sutures for abdominal fascial closure after laparotomy in patients with suspected impaired wound healing. Br J Surg. 1995;82:1698-1699.
20. Torzewski M, Sarbia M, Verreet P, et al. Prognostic significance of urokinase-type plasminogen activator expression in squamous cell carcinoma of esophagus. Clin Cancer Res. 1997;3:2263-2268.
21. Nekarda H, Schlegel P, Schmitt M, et al. Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus. Clin Cancer Res. 1998;4:1755-1763.
22. Artym VV, Kindzelski AL, Chen W-T, Petty HR. Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta 1 integrins and cytoskeleton. Carcinogenesis. 2002;23:1592-1601.
23. WHO. WHO Histological Typing of Esophageal and Gastric Tumors. Geneva: WHO; 1990;20-26.
24. UICC, TNM Atlas, ed 5. An Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors. Digestive System Tumors. Heidelberg: Springer-Verlag; 2005:74-83.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
26. Kohga S, Harvey S, Marcus G. Localisation of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res. 1985;45:1787-1796.
27. Skriver L, Larsson LI, Kielberg V, et al. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J Cell Biol. 1984;99:752-757.
28. Gaylis FD, Keer HD, Wilson MJ, Kwaan HC, Sinha AA, Kozlowski JM. Plasminogen acivators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype. J Urol. 1989;142:193-198.